FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

INMED PHARMACEUTICALS INC.: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2025-07-01 – 2026-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/5d707c1d-1ad3-49d2-aed3-1ca2b3be80ac

Reported value

$0{"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
INMED PHARMACEUTICALS INC.
Metric
cashflow_investing
Period
2025-07-01 – 2026-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-26-386611 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-09-11T08:45:49.406688+02:00
Raw response SHA-25688c5b850bbd8a9199c3419c3dc02098c…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001728328/cashflow-investing/2026-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.